Metabolic correlation and management strategies of non-alcoholic fatty liver disease: An Asian Indian perspective

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 1, Issue 4, 2007, Pages 279-285

  Luthra, Atul ^a   Nigam, Priyanka ^b   Misra, Anoop ^a,b  

^a FORTIS HOSPITAL   (India)

^b Diabetes Foundation India New Delhi   (India)

Author keywords

Asian Indians; Insulin resistance, Metabolic syndrome; Insulin sensitizers; Non alcoholic fatty liver disease

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMINOTRANSFERASE; ANTIOXIDANT; BETAINE; DIETHANOLAMINE; GLITAZONE DERIVATIVE; INSULIN; INSULIN SENSITIZING AGENT; INTERLEUKIN 6; LOSARTAN; METFORMIN; NICOTINAMIDE; PENTOXIFYLLINE; PIOGLITAZONE; PLACEBO; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; URSODEOXYCHOLIC ACID;

AMINOTRANSFERASE BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BARIATRIC SURGERY; BODY MASS; CALORIC RESTRICTION; CAUCASIAN; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EDEMA; GASTROINTESTINAL SYMPTOM; HUMAN; INDIAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER CIRRHOSIS; LIVER FIBROSIS; LOW FAT DIET; METABOLIC SYNDROME X; MONOTHERAPY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOGENESIS; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK FACTOR; SIDE EFFECT; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 35448960732     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2007.09.005     Document Type: Review

References (44)

1. Meigs J. Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all?. Am J Epidemiol 152 (2000) 908-911
2. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37 (2003) 917-923
3. Brent A., Neuschwander-Teri B., and Caldwell S. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37 (2003) 1202-1219
4. Chitturi S., Farrell G., and George J. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?. J Gastroenterol Hepatol 19 (2004) 368-374
5. Akahoshi M., Amasaki Y., Soda M., Tominaga T., Ichimaru S., Nakashima E., et al. Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan. Hypertens Res 24 (2001) 337-343
6. Lai S., and Ng K. Which anthropometric indices best predict metabolic disorders in Taiwan?. South Med J 97 (2004) 578-582
7. Amarapurkar D., and Amarapurkar A. Nonalcoholic steatohepatitis: clinicopathological profile. J Assoc Phys India 48 (2000) 311-313
8. Agarwal S., Malhotra V., Sakhuja P., and Sarin S. Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. Indian J Gastroenterol 20 (2001) 183-186
9. Amarapurkar D., and Patel N. Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis. Trop Gastroenterol 25 (2004) 125-129
10. Singh S., Nayak S., Swain M., Raut N., Mallik R., Agrawal O., et al. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Trop Gastroenterol 25 (2004) 76-79
11. Baba S., Alexander G., Kalyani B., Pandey P., Rastogi S., Pandey A., et al. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. Indian J Gastroenterol 22 suppl. 1 (2003) A4 [abstract]
12. Amarapurkar A., and Ghansar T. Fatty liver: experience from western India. Ann Hepatol 6 (2007) 37-40
13. Marchesini G., Brizi M., Morselli-Labate A., Bianchi G., Bugianesi E., McCullough A.J., et al. Association of non-alcoholic fatty liver disease with insulin resistance. Am J Med 107 (1999) 450-455
14. Chitturi S., Abeygunasekera S., Farrell G., Holmes-Walker J., Hui J., Fung C., et al. NASH and insulin resistance: insulin secretion and specific association with the insulin resistance syndrome. Hepatology 35 (2002) 373-379
15. Angelico F., Del Ben M., Conti R., Francioso S., Feole K., Fiorello S., et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 90 (2005) 1578-1582
16. Seppälä-Lindroos A., Vehkavaara S., Häkkinen A., Goto T., Westerbacka J., Sovijärvi A., et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87 (2002) 3023-3028
17. Garg A., and Misra A. Hepatic steatosis, insulin resistance and adipose tissue disorder. J Clin Endocrinol Metab 87 (2002) 3019-3022
18. Brea A., Mosquera D., Martin E., Arizti A., Cordero J., and Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 25 (2005) 1045-1050
19. Hamaguchi M., Kojima T., Takeda N., Nagata C., Takeda J., Sarui H., et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gasterroenterol 13 (2007) 1579-1584
20. Targer G., and Arcaro G. Nonalcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 192 (2007) 235-240
21. Wasir J., and Misra A. The metabolic syndrome in Asian Indians: the impact of nutritional and socio-economic transition in India. Met Syndr Relat Disord 2 (2004) 14-23
22. Misra A., and Misra R. Asian Indians and Insulin Resistance Syndrome: Global Perspective. Met Syndr Relat Disord 1 (2003) 277-285
23. Misra A., and Vikram N. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Curr Sci 83 (2002) 1483-1496
24. Vikram N., Misra A., Pandey R., Dwivedi M., and Luthra K. Adiponectin levels in postpubertal Asian Indian adolescents: Relationships with insulin resistance and C-reactive protein. Metabolism 53 (2004) 1336-1341
25. Misra A., Vikram N., Arya S., Pandey R., Dhingra V., Chatterjee A., et al. High prevalence of insulin resistance in postpubertal Asian Indian children is associated with adverse truncal body fat patterning, abdominal adiposity and excess body fat. Int J Obes 28 (2004) 1217-1226
26. Misra A., and Vikram N. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 19 (2003) 457-466
27. Misra A., and Vikram N. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition 20 (2004) 482-491
28. Misra A., Sharma R., Pandey R., and Khanna N. Adverse profile of dietary nutrients, anthropometry and lipids in urban slum dwellers of northern India. Eur J Clin Nutr 55 (2001) 727-734
29. ShulmanI G., Petersen K., Dufour S., Feng J., Befroy D., Dziura J., et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA 103 (2006) 18273-18277
30. Hickman I., Jonsson J., Prins J., Ash S., Purdie D., Clouston A., et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin and quality of life. Gut 53 (2004) 413-419
31. Dixon J., O'Brien P., and Bhathal P. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39 (2004) 1647-1654
32. Uygun A., Kadayifci A., Isik A., Ozgurtas T., Deveci S., Tuzun A., et al. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 19 (2004) 537-544
33. Nair S., Diehl A., Wiseman M., Farr Jr. G., and Perrillo R. Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. Aliment Pharmacol Ther 20 (2004) 23-28
34. Bugianesi E., Gentilcore E., Manini R., Natale S., Vanni E., Villanova N., et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 100 (2005) 1082-1090
35. Promrat K., Lutchman G., Uwaifo G., Freedman R., Soza A., Heller T., et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 39 (2004) 188-196
36. Sanyal A., Mofrad P., Contos M., Sargeant C., Lucetic V., Sterling R., et al. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2 (2004) 1107-1115
37. Lavine J. Vitamin E treatment of non-alcoholic steatohepatitis in children: a pilot study. J Pediatr 136 (2000) 734-738
38. Hasegawa T., Yoneda M., Nakamura K., Makino I., and Terano A. Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther 15 (2001) 1667-1672
39. Laurin J., Lindor K., Crippin J., Gossard A., Gores G., Ludwig J., et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 23 (1996) 1464-1467
40. Ceriani R., Bunati S., Morini L., Sacchi E., and Colombo G. Effect of ursodeoxycholic acid plus diet in patients with non-alcoholic steatohepatitis. Hepatology 28 part 2 suppl. (1998) 894 [Abstract]
41. Abdelmalek M., Angulo P., Jorgensen R., Sylvestre P., and Lindar K. Betaine, a promising new agent for patients with non-alcoholic steatohepatitis: results of a pilot study. Am J Gastroenterol 96 (2001) 2711-2717
42. Yokohama S., Yoneda M., Haneda M., Okamoto S., Okada M., Aso K., et al. Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. Hepatology 40 (2004) 1222-1225
43. Adams L., Zein C., Angulo P., and Lindor K. A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am J Gastroenterol 99 (2004) 2365-2368
44. Gulbahar O., Karasu Z., Ersoz G., Akarca U., and Musoglu A. Treatment of non-alcoholic steatohepatitis with N-acetylcysteine. Gastroenterology 118 part 2 suppl. (2000) 6550 [Abstract]